Alzheimer-kór trials, also abroad
822 open Alzheimer-kór trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Ország | Open trials |
|---|---|
| Egyesült Államok | 361 |
| Kína | 134 |
| Franciaország | 85 |
| Olaszország | 60 |
| Kanada | 58 |
| All other countries |
The same trial often runs in several countries
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) has 3 sites in Chile and runs in 31 countries. If a site near you is full, another one may still take people.
See Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) in all 31 countries